LifePro Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,980
Closed -$235K 169
2024
Q2
$235K Buy
2,980
+13
+0.4% +$1.07K 0.17% 113
2024
Q1
$259K Sell
2,967
-88
-3% -$7.51K 0.17% 108
2023
Q4
$252K Sell
3,055
-151
-5% -$11.5K 0.19% 88
2023
Q3
$251K Buy
3,206
+87
+3% +$7.28K 0.21% 84
2023
Q2
$275K Buy
+3,119
New +$269K 0.21% 87

Other funds holding MDT

LifePro Asset Management's MDT Position: Q3 2024 in Review

LifePro Asset Management sold out of Medtronic (MDT) in Q3 2024, closing a stake of 2,980 shares — an estimated $235K sold.

LifePro Asset Management first reported a position in MDT in Q2 2023 and held it in 5 quarters. The position peaked at $275K in Q2 2023. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • LifePro Asset Management reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • LifePro Asset Management sold 2,980 Medtronic shares in Q3 2024, an estimated $235K.
  • LifePro Asset Management first reported a position in Medtronic in Q2 2023 and held it in 5 quarters.
  • LifePro Asset Management's Medtronic position peaked at $275K in Q2 2023.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.